MDXG— MIMEDX GROUP, INC.

Health CareBiotechnology$627M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Net sales	$418.6M+20.0%	$348.9M+8.5%	$321.5M+20.0%	$267.8M
Cost of sales	$73.0M+21.5%	$60.1M+10.0%	$54.6M+13.1%	$48.3M
Gross profit	$345.6M+19.7%	$288.8M+8.2%	$266.8M+21.6%	$219.5M
Selling, general and administrative	$266.2M+18.3%	$225.1M+6.6%	$211.1M+1.2%	$208.7M
Research and development	$15.1M+22.3%	$12.3M-2.6%	$12.7M-0.3%	$12.7M
Investigation, restatement and related	$0+100.0%	-$8.7M-268.0%	$5.2M-57.5%	$12.2M
Amortization of intangible assets	$439K-42.6%	$765K+0.4%	$762K+8.7%	$701K
Impairment of intangible assets	$0-100.0%	$446K	$0	$0
Operating income	$63.9M+8.5%	$58.9M+58.6%	$37.1M+352.0%	-$14.7M
Other income (expense), net	—	—	—	—
Interest income (expense), net	$2.9M+391.6%	-$1.0M+84.4%	-$6.5M-28.7%	-$5.0M
Other expense, net	-$558K+1.2%	-$565K-2073.1%	-$26K-550.0%	-$4K
Income from continuing operations before income tax	$66.3M+15.7%	$57.3M+87.0%	$30.6M+255.1%	-$19.7M
Income tax provision (expense) benefit from continuing operations	-$17.7M-15.6%	-$15.3M-141.6%	$36.8M+17967.0%	-$206K
Net income from continuing operations	$48.6M+15.7%	$42.0M-37.7%	$67.4M+438.0%	-$20.0M
Income (loss) from discontinued operations, net of tax	$0-100.0%	$421K+104.6%	-$9.2M+10.1%	-$10.2M
Net income	$48.6M+14.5%	$42.4M-27.2%	$58.2M+292.8%	-$30.2M
Net income available to common stockholders from continuing operations	$48.6M+15.7%	$42.0M-24.7%	$55.8M+310.3%	-$26.5M
Continuing operations - basic (in dollars per share)	$0.33+13.8%	$0.29-39.6%	$0.48+300.0%	-$0.24
Discontinued operations - basic (in dollars per share)	$0.00	$0.00+100.0%	-$0.08+11.1%	-$0.09
Basic net income per common share (in dollars per share)	$0.33+13.8%	$0.29-27.5%	$0.40+221.2%	-$0.33
Continuing operations (in dollars per share)	$0.32+14.3%	$0.28-34.9%	$0.43+279.2%	-$0.24
Discontinued operations (in dollars per share)	$0.00	$0.00+100.0%	-$0.06+33.3%	-$0.09
Diluted net income (loss) per common share (in dollars per share)	$0.32+14.3%	$0.28-24.3%	$0.37+212.1%	-$0.33
Weighted average shares outstanding - basic (in shares)	147.8M+0.6%	147.0M+26.2%	116.5M+3.2%	112.9M
Weighted average shares outstanding - diluted (in shares)	149.7M+0.5%	149.0M+2.1%	146.0M+29.3%	112.9M

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 12 more years of annual history and full quarterly detail on Pro.

Upgrade to Pro →

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.